UA74095U - Препарат для лечения туберкулеза - Google Patents

Препарат для лечения туберкулеза

Info

Publication number
UA74095U
UA74095U UAU201208962U UAU201208962U UA74095U UA 74095 U UA74095 U UA 74095U UA U201208962 U UAU201208962 U UA U201208962U UA U201208962 U UAU201208962 U UA U201208962U UA 74095 U UA74095 U UA 74095U
Authority
UA
Ukraine
Prior art keywords
drug
tuberculosis
treatment
medicine
chemical
Prior art date
Application number
UAU201208962U
Other languages
English (en)
Ukrainian (uk)
Inventor
Николай Иванович Гуменюк
Original Assignee
Николай Иванович Гуменюк
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Николай Иванович Гуменюк filed Critical Николай Иванович Гуменюк
Publication of UA74095U publication Critical patent/UA74095U/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Препарат для лечения туберкулеза относится к химико-фармацевтической промышленности и медицине. Новый состав препарата позволяет повысить температуру хранения препарата, что важно при его транспортировке и хранении.
UAU201208962U 2012-07-20 2012-07-20 Препарат для лечения туберкулеза UA74095U (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA201208962 2012-07-20

Publications (1)

Publication Number Publication Date
UA74095U true UA74095U (ru) 2012-10-10

Family

ID=56889302

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201208962U UA74095U (ru) 2012-07-20 2012-07-20 Препарат для лечения туберкулеза

Country Status (6)

Country Link
AP (1) AP2015008270A0 (ru)
BR (1) BR112015001275A2 (ru)
EA (1) EA025861B1 (ru)
RU (1) RU2648822C2 (ru)
UA (1) UA74095U (ru)
WO (1) WO2014014434A1 (ru)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495534B2 (en) * 2000-05-15 2002-12-17 Pharmacia & Upjohn Spa Stabilized aqueous suspensions for parenteral use
CN102458421A (zh) * 2009-05-28 2012-05-16 欧布谢斯特沃公司 药用试剂

Also Published As

Publication number Publication date
AP2015008270A0 (en) 2015-02-28
RU2015106366A (ru) 2016-09-10
RU2648822C2 (ru) 2018-03-28
BR112015001275A2 (pt) 2018-01-30
EA025861B1 (ru) 2017-02-28
WO2014014434A1 (ru) 2014-01-23
EA201590243A1 (ru) 2015-06-30

Similar Documents

Publication Publication Date Title
CO7190242A2 (es) Moduladores del transporte nuclear y usos de los mismos
DK2925272T3 (da) Lægemiddelopbevarings-, udleverings- og administrationssystem
IL238713A0 (en) Self-regulating active pharmaceutical ingredient release
GB201512336D0 (en) Blister pack for storage and sterilization of inside contained objects
EP2815769A4 (en) PHARMACEUTICAL USE OF FAM19A5 IN A GLIOGENESIS REGULATION
IL233813A0 (en) Tray system for displaying, storing and transporting bottles
HUE038904T2 (hu) Elsõdleges csomagolás orvosi vagy gyógyszerészeti összetételek tárolására és/vagy beadására
HK1205450A1 (en) Medicine comprising combination of general anesthetic drug and hydrogen
UY34786A (es) Procedimiento para la fabricación de una forma farmacéutica que comprende nifedipino y candesartan cilexetilo
FR2997321B1 (fr) Installation de stockage et de delivrance de boites de medicaments
CO7200262A2 (es) Nueva dosificación y formulación
UY34931A (es) ?formulación compuesta para administración oral que comprende metformina y rosuvastatina?.
HK1203149A1 (en) Novel dosage form and formulation of abediterol
AU201613322S (en) A Compliance Monitor for a Medicament Inhaler
PL2874600T3 (pl) Kompozycja farmaceutyczna do leczenia chrypki lub bólów gardła.
GB201419374D0 (en) Childproof storage and timing device for administration of medicine
SI2656843T1 (sl) Estri bendamustina in povezane spojine ter njihova medicinska uporaba
HUP1600414A2 (hu) Bisoprololt és ramiprilt tartalmazó stabil kombinációs gyógyszerkészítmény
UA74095U (ru) Препарат для лечения туберкулеза
EA201500313A1 (ru) Стабилизированная аморфная форма агомелатина, способ ее изготовления и фармацевтические композиции, ее содержащие
HK1203955A1 (zh) 反式- -癸烯酸衍生物及含有其的藥物
FR3011536B1 (fr) Conteneur de stockage et de transport de marchandises
UA74097U (ru) Способ изготовления средства для лечения туберкулеза
UA75204U (ru) Спазмолитический и седативный препарат в форме мягких желатиновых капсул
AU367396S (en) A compliance monitor for a medicament inhaler